AiMedics HomePage

Management

Executive

Mr Victor Skladnev BSc. MEng. FAICD
Chief Executive Officer / Executive Director
Victor has held chief executive and board positions in both public and private biotechnology companies over the past 15 years. During this period he has managed the development and marketing of a number of award winning products including technology ranked as amongst the best produced in Australia. Victor has served on a number of committees including the CSIRO sector advisory board.

		Dr Nejhdeh Ghevondian BE ME PhD Chief Technical Officer Nejhdeh Ghevondian has been involved in managing R&D projects throughout number of biomedical and computer engineering companies. Nejhdeh has taken projects from design concepts, right through to clinical data collection and production, including systems such as breast cancer detection, ECG analysis and non-invasive monitoring devices. He has vast project management and technical skills, with specific expertise in product design, software engineering principles, enterprise software architecture, complex mathematical computation and cluster programming.

Board

Mr Martin Greenberg B.Bus, DipComm, FCPA, JP
Independent Chairman
Martin is Managing Director of Apollan Investments Group a Sydney based company specializing in venture capital, corporate finance, securities and general investment. From 1986-1999 Martin was a Director of Babcock & Brown, the International Investment Bank. Prior to this he was a Director of Morgan Grenfell Australia Limited and prior to this Senior Vice President with Security Pacific Group in London. Martin has been a Director of several public companies in Australia and New Zealand and has an extensive range of national and international contacts and experience built up over the past 30 years. Currently he is Chairman of Selector Funds Management Ltd and and a Director of NewGen/ERM Power Group and Liquid Capital Management Pty Ltd. He was formerly Chairman of Promics Limited. Martin holds a Bachelor of Business(UTS), Diploma of Commerce(UTS), Fellow CPA and a Justice of Peace. He is also a judge of the annual AVCAL awards.

Richard Caldwell BEc LLB(Syd) ASIA
Non-executive Director
Richard is a founding shareholder and non-executive director of AiMedics. He has recently resigned from Head of Corporate Finance at Stonebridge Equities in Sydney after 24 years in investment banking and trading to pursue a full-time role as executive chairman of Dyesol Limited, an ASX listed solar energy company. Beyond the City, Richard is an honorary governor and past president of The Medical Foundation, one of Australia's largest private medical research foundations and also a visiting fellow of Macquarie University, where he teaches Equity Capital Markets in the Masters of Applied Finance.

Dr Steve Gourlay MBBS PhD MBA
Non-executive Director
Dr Steve Gourlay is a partner at GBS Ventures Partners, Australia’s largest life sciences venture firm. He has more than 15 years experience in drug and medical device development (Monash University, University of California, San Francisco, Genentech, Life Science Angels). Steve is on the board of directors of four medical device companies in Sydney and is a licensed consultant physician in Internal & Vascular Medicine. He received his PhD in Medicine from Monash University (clinical epidemiology, clinical trial methodology), his postdoc from UCSF (Phase I studies) and his MBA from Macquarie University.

Peter Spencer MBA PhD MAICD
Non-executive Director
Dr Peter Spencer has over 25 years experience in the Healthcare Industry in the USA, Australia and Germany. He has worked in a range of senior positions within Johnson and Johnson Inc for 14 years as well as several Start-up companies which have resulted in the successful commercialisation of a number of new businesses. He has qualifications in Science (USyd, BSc), Chemical Engineering BE (USyd, Hons 1), Biomedical Engineering (UNSW, PhD) and a Masters Degree in Business (Columbia University NY, MBA, Hons Soc).

Scientific Advisory Board

Professor Hung Nguyen AM PhD
Scientific Advisor
Hung Nguyen has been Professor of Electrical Engineering at the University of Technology, Sydney (UTS) since 2001. Currently, he is the Associate Dean of Research and Development in the Faculty of Engineering (UTS) and Director (Engineering) of the Key University Research Centre for Health Technologies. In 2002, he was appointed a Member in the General Division of the Order of Australia (AM). He is an experienced consultant for numerous control, computer, biomedical and electronic companies with more than 150 publications.

Associate Professor Timothy W Jones MD
Scientific Advisor
Associate Professor Jones is Head of Department of Diabetes and Endocrinology at Princess Margaret Hospital for Children Perth and Clinical Associate Professor at the Western Australian Institute of Child Heath Research. His major clinical and research interest is in Diabetes in children and adolescents with a specific focus on the problem of hypoglycaemia. In addition to leading his own research group in Australia Dr Jones is an investigator with the Yale Diabetes Research Center. Dr Jones is also a member of the Australian Paediatric Endocrine Group Council and the Scientific Review Committee of the Juvenile Diabetes Research Foundation International.

		Professor Stephen Colagiuri MD Scientific Advisor Professor Colagiuri is the chairman of the Department of Endocrinology, Diabetes and Metabolism, and the director of Diabetes Services, at the Prince of Wales Hospital, Sydney. Prof. Colagiuri is a member of institutions such as the Australian Government National Diabetes Strategy Group, the National Vascular Disease Prevention Partnership and the International Diabetes Federation (IDF) Screening for Type II Diabetes Working Party. He has also been past president of the Australian Diabetes Society (ADS) and a medical advisor to Diabetes Australia.

Professor David Owens MD
Scientific Advisor
Professor Owens is the director of the Diabetes Research Unit, located at Llandough Hospital, Cardiff, Wales. In 1998, Llandough became the home of the first Health Authority wide Diabetic Retinopathy Screening Services in UK under Prof. Owens guidance. He has long been involved in the development of new treatments for diabetes, resulting into number of international journal publications.